Imunon, Inc. (IMNN) short interest & options flow
NASDAQImunon enters the final stretch before its May 14 Q1 results with an unusually sharp contrast: a freshly initiated Buy rating and a $10 price target from Maxim Group against a stock trading at $2.75 — and a cash runway that runs only into the second half of 2026. The Maxim initiation on April 17 is the dominant event of this week. Analyst Jason McCarthy set a $10 target, implying…
- Market cap
- $4M
- Next earnings
- 30 Mar 2027
Key data as of 12 Nov 2026

IMNN news and analysis
RSSNo long-form analysis yet for IMNN. Pulse alerts and the live data picture are available on ORTEX.
Open IMNN on ORTEX →Want the live picture for IMNN?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IMNN — free to start on ORTEX.
Sign up for free →Open IMNN on ORTEX